Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Hot Flashes 7Head and Neck Neoplasms 7Breast Neoplasms 7Pain, Postoperative 4Prostatic Neoplasms 3Pain 3Vomiting 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Neuralgia 2Neoplasms 2Nausea 2Mucositis 2Depression 2Anxiety Disorders 2Agnosia 2Acute Pain 2Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Rectal Neoplasms 1Psychotic Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Myalgia 1Lymphoma, Follicular 1Lung Neoplasms 1Laryngeal Diseases 1Ileus 1

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Tomography, Emission-Computed, Single-Photon 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abnormalities, Radiation-Induced × Gabapentin × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡